Related Experiment Video
Updated: Aug 13, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Katarzyna Ulanowska1, Grzegorz Wegrzyn
1Department of Molecular Biology, University of Gdansk, Kladki 24, 80-822 Gdansk, Poland.
Abstract:
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin, which can damage dopaminergic neurons. It causes symptoms resembling those observed in patients suffering from Parkinson's disease, and hence this toxin is widely used in studies on animal models of this disorder. Mutagenicity of MPTP was also reported by some authors, but results obtained by others suggested that this compound is not mutagenic. Interestingly, those contrasting results were based on the same assay (the Ames test). Therefore, we aimed to test MPTP mutagenicity by employing a recently developed Vibrio harveyi assay, which was demonstrated previously to be more sensitive than the Ames test, at least for some mutagens. We found that MPTP showed a significant mutagenic activity. Moreover, MPTP mutagenicity was attenuated by methylxanthines, compounds that are known to form complexes with aromatic mutagens.
Insights
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that damages dopaminergic neurons. This study found MPTP to be mutagenic using a sensitive Vibrio harveyi assay, with activity reduced by methylxanthines.
Area of Science:
- Neuroscience
- Toxicology
- Genetics
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that selectively damages dopaminergic neurons.
- MPTP is utilized in animal models to study Parkinson's disease due to its ability to induce Parkinsonian symptoms.
- Conflicting data exists regarding the mutagenicity of MPTP, with some studies reporting it as mutagenic while others conclude it is not, based on the Ames test.
Purpose of the Study:
- To investigate the mutagenicity of MPTP using a more sensitive assay.
- To determine if methylxanthines can attenuate the mutagenic effects of MPTP.
Main Methods:
- Utilized the Vibrio harveyi assay to assess the mutagenicity of MPTP.
- Investigated the effect of methylxanthines on MPTP-induced mutagenicity.
Main Results:
- MPTP demonstrated significant mutagenic activity in the Vibrio harveyi assay.
- Methylxanthines were found to attenuate the mutagenicity of MPTP.
- The Vibrio harveyi assay proved more sensitive for detecting MPTP mutagenicity compared to the Ames test.
Conclusions:
- MPTP possesses significant mutagenic potential.
- Methylxanthines can counteract the mutagenic effects of MPTP, possibly through complex formation.
- The Vibrio harveyi assay offers a more sensitive platform for evaluating the mutagenicity of compounds like MPTP.
Related Concept Videos
Spontaneous and Induced Mutations
Mutagenicity and Carcinogenicity
Aromatic Hydrocarbon Cations: Structural Overview
Removing one hydrogen from the intervening CH2 group with both...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Physical Properties of Amines
Bioactivation and Tissue Toxicity

